A Mitochondrial-Targeting Near-Infrared Fluorescent Probe for Bioimaging and Evaluating Endogenous Superoxide Anion Changes During Ischemia/reperfusion Injury

Xiaoyue Han,Rui Wang,Xinyu Song,Fabiao Yu,Changjun Lv,Lingxin Chen
DOI: https://doi.org/10.1016/j.biomaterials.2017.11.039
IF: 14
2018-01-01
Biomaterials
Abstract:The outburst of superoxide anion (O-2(center dot-)) in mitochondrial during ischemia/reperfusion (I/R) process will cause a series of oxidative damage including polarity loss of mitochondrial membrane potential, overload of secondary cellular calcium, and cascade apoptosis. To monitor the O-2(center dot-) level fluctuations as well as to evaluate the relationship between O-2(center dot-) concentration and the degree of cell apoptosis during I/R process, we propose a ratiometric near-infrared mitochondrial targeting fluorescent probe Mito-Cy-Tfs for the detection of level changes of O-2(center dot-) in cells and in vivo. The probe Mito-Cy-Tfs is composed of three moieties: near-infrared heptamethine cyanine as fluorescence signal transducer, trifluoromethanesulfonamide as fluorescence modulator, and lipophilic triphenylphosphonium cation as mitochondrial guider. The probe can well locate in mitochondria and respond the concentration changes of endogenous O-2(center dot-) selectively and sensitively. The probe has been successfully utilized to image the endogenous O-2(center dot-) fluctuations in four kinds of cell I/R models (glucose deprivation/reperfusion, serum deprivation/reperfusion, oxygen deprivation/reperfusion and glucose-serum-oxygen deprivation/reperfusion). The probe also exhibits deep tissue penetration for real-time imaging of O-2(center dot-) concentration in liver of I/R mice model. We confirm that the adoption of ischemic preconditioning (IPC) and postconditioning (IPTC) can protect liver from I/R injury. The probe can be employed to accurately indicate and evaluate the mutual relationship between the levels of O-2(center dot-) and the degrees of organ damage during I/R, IPC and IPTC processes. The above applications make our new probe a potential candidate for the clinical surgery assessment. (C) 2017 Elsevier Ltd. All rights reserved.
What problem does this paper attempt to address?